Sign in Create account

BIOGEN PHARMACHEM INDUSTRIES LIMITED

Financial Services · Finance

BSE: 531752
₹0.28
▲ 0.01 (3.70%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
78/100
Strong
Valuation
100/100
Undervalued
Momentum
45/100
Neutral

QVM read Quality at a discount Quality Strong, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹29 Cr
PE (TTM)
Data unavailable.
Price to Book
0.3
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-65.7
Free Cash Flow
₹2 Cr
as of March 31, 2026
Industry median ₹-0 Cr (536 companies)
EPS Growth (YoY)
-100.00%
as of June 30, 2026
Industry median 25.00% (187 companies)
Net Profit Growth (TTM)
-34.40%
as of June 30, 2026
Industry median 0.00% (481 companies)
Operating Revenue Growth (TTM)
12.67%
as of June 30, 2026
Industry median 0.00% (476 companies)
Profit Growth (YoY)
-83.57%
as of June 30, 2026
Industry median 12.66% (188 companies)
Revenue Growth (YoY)
-71.29%
as of June 30, 2026
Industry median 8.05% (138 companies)
Current Ratio
2.27
as of March 31, 2026
Industry median 5.29 (212 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.00 (206 companies)
Interest Coverage
13.20
as of Dec. 31, 2025
Industry median 2.05 (385 companies)
Net Margin
49.89%
as of June 30, 2026
Industry median 21.71% (183 companies)
Operating Margin (EBIT)
49.89%
as of June 30, 2026
Industry median 29.93% (192 companies)
Operating Margin (TTM)
-6.79%
as of June 30, 2026
Industry median 31.63% (395 companies)
Return on Assets
0.96%
as of March 31, 2026
Industry median 0.85% (493 companies)
Return on Capital Employed
0.96%
as of March 31, 2026
Industry median 1.93% (197 companies)
Return on Equity
0.96%
as of March 31, 2026
Industry median 1.37% (491 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (1.0%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 2 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
3.7%
Low 0.2600 · High 0.2800
1W return
0.0%
Low 0.2600 · High 0.2800
1M return
0.0%
Low 0.2500 · High 0.3000
52W return
-76.1%
Low 0.2500 · High 0.3000
Lifetime High ₹1.8200 (Feb. 11, 2022)
Lifetime Low ₹0.0400 (July 9, 2013)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
0.3
10D
0.3
20D
0.3
50D
0.5
100D
0.7
200D
1.0

Delivery and volume

Day avg. delivery
56.7%
Week avg. delivery
57.5%
Month avg. delivery
56.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

0.27
Pivot
First resistance0.29
Second resistance0.29
Third resistance0.31
First support0.27
Second support0.25
Third support0.25
Day RSI36.1
Day MFI61.0
Day MACD-0.04
Day MACD signal-0.06

Beta

1M0.98
3M1.03
1Y1.03
3Y0.81

Price change analysis

↑ 0.0%
Over 1 Month
LowHigh
0.250.30
↓ -76.1%
Over 3 Months
LowHigh
0.250.30
↓ -76.1%
Over 6 Months
LowHigh
0.250.30
↓ -76.1%
Over 1 Year
LowHigh
0.250.30
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.0000

Ranks #296 of 510 in Finance by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026

Largest holders

Data unavailable.

All shareholding details →

Deals (Bulk & Block)

All 304 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
4 May 2026 MOHANRAMESH Bulk Buy 5,100,000 0.4900 BSE
10 Jul 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 3,355,000 1.3000 BSE
9 Jul 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 1,085,901 1.4400 BSE
9 Jul 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Buy 4,440,901 1.4400 BSE
5 Jul 2024 JAI VINAYAK SECURITIES Bulk Buy 3,274,609 1.7200 BSE
5 Jul 2024 JAI VINAYAK SECURITIES Bulk Sell 3,620,035 1.7000 BSE
3 Jul 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Sell 3,291,682 1.2500 BSE
3 Jul 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Buy 3,778,839 1.2300 BSE
3 Jul 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Buy 3,780,832 1.2300 BSE
3 Jul 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 3,780,832 1.2300 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Sun Techno Overseas Ltd to BIOGEN PHARMACHEM INDUSTRIES LIMITED
—NAME_CHANGEName changed from WELLWORTH OVERSEAS LTD. to Sun Techno Overseas Ltd

All corporate actions →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 AGM/EGM Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Outcome of AGM
4 Sep 2026 AGM/EGM Biogen Pharmachem Industries Ltd - 531752 - Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
4 Sep 2026 Corp. Action Biogen Pharmachem Industries Ltd - 531752 - Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
4 Sep 2026 Others Biogen Pharmachem Industries Ltd - 531752 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (49.9%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (13.2x)
  • Healthy liquidity (Current Ratio 2.27)

Weaknesses

  • Low Return on Equity (1.0%)
  • Declining revenue YoY (-71.3%)
  • Declining profit YoY (-83.6%)

Opportunities

  • Trading below book value (PB 0.30)

Threats

  • Down 76.1% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about BIOGEN PHARMACHEM INDUSTRIES LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.